Is MYX a bargain, page-1958

They aren’t obliged to as they provided no profit
guidance at the half year results and will feel quite
justified with their actions. No disclosure required
as far as they’re concerned. At least they maintain
a consistent approach of silence unless forced to
disclose during confession season. Any slight up
lift in profits will allow retails to attempt to exit and
reduce some of the financial damage done. Any
further slide in profits will see the writing on the wall
and a stampede for the exits as shorts once again
load up and teach management a lesson they aren’t
willing to learn. And there in lies the problem. Most
people could see the rot 12 months ago and déjà
vue this year yet again. A company so far out of
their depth. SR may still get the opportunity of
presiding over a corporate failure or a slightly better
scenario of a CR for sophisticated investors only,
of course, with an eye for value and vision for the
future....but don’t expect an SR buy in. This is a lesson
in grandiose planning and gross financial mismanagement.
Stephen Mayne probed about a CR last year and given
the continued share price slide it would surely have to be
on the cards. Even some of the banks have had to tap the market
to ensure ongoing financial viability so I can’t see why it
won’t happen again. If it does then share holders will be
paying for the Teva deal twice and won’t be too happy when
they see the dilution reality check confirming beyond a shadow
of a doubt the wealth destruction caused by SR and his cronies
that will especially hurt retails who have nothing left to give this
company. Not to worry SR will go merrily on his way and if given
the flick will get a handsome pay out and use his 30 year
pharmaceutical experience to get a resume together and secure
a new role somewhere else. Can just see it now. He’ll talk himself
right up and share holders will applaud fresh eyes and vision whilst
he secures himself a big package given his “expertise” in the
pharmaceutical industry....